MarketPeel
Insider Trading Intelligence
KH

Kristopher Hanson

MPLT
GENERAL COUNSEL · MAPLIGHT THERAPEUTICS, INC. · CIK 0001789970
FILING MIX · LIFETIME25%/75%
BUYS
4
SELLS
12
TOTAL VALUE
$1.32M
COMPANIES
1
ACTIVE SINCE
Oct 2025
HOLDINGS NOW
175,118
AVG SELL PX
$23.79
TRADE KIND
SHOWING 16 / 16
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
11 backtested trades · 8 horizons · 48 pending
Forward-return performance of every backtestable P/S trade by Kristopher Hanson, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d11+36.36%+3.06%+1.55%+1.52%+1.14%
14d11+36.36%+2.53%+2.86%+3.66%-1.01%
30d11+36.36%+1.40%+2.35%-1.49%-1.79%
60d11(4 pending)+0.00%+15.38%+4.62%+10.77%+21.54%
90d11(11 pending)
180d11(11 pending)
1y11(11 pending)
2y11(11 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
MPLT · 175,118 shares · as of May 11, 2026
047,89695,791143,687191,5822026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2025
2026
2026
FLOW · 4 buys / 12 sellsCOVERAGE · 3 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
6,979$30.04$209.6K168,139May 11, 2026May 11, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,808$30.56$177.5K162,331May 11, 2026May 11, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
284$27.61$7.8K175,964May 11, 2026May 11, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
846$28.70$24.3K175,118May 11, 2026May 11, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,908$28.29$110.6K177,227May 4, 2026May 6, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
9,030$27.50$248.3K181,135May 4, 2026May 6, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
296$29.56$8.7K176,931May 4, 2026May 6, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
683$30.08$20.5K176,248May 4, 2026May 6, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE
General Counsel
225$27.49$6.2K190,165Apr 16, 2026Apr 17, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE
General Counsel
73$27.01$2.0K190,390Apr 16, 2026Apr 17, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE
General Counsel
1,529$26.80$41.0K190,463Apr 15, 2026Apr 17, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
7,730191,582Feb 5, 2026Feb 9, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
31,39531,395Feb 5, 2026Feb 9, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE
General Counsel
26,007$17.98$467.6K183,852Jan 27, 2026Jan 29, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
110,046110,046Oct 27, 2025Oct 28, 2025View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
27,09827,098Oct 27, 2025Oct 28, 2025View →
Other insiders · MPLT
Loading peer insiders…
About this filer
CIK 0001789970
ROLE
General Counsel
PRIMARY
MPLT
COMPANIES
1
ACTIVE SINCE
Oct 2025
MARKETPEEL · /INSIDER/0001789970DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback